As of 2025-06-23, the Fair Value of Revive Therapeutics Ltd (RVV.CN) is -0.05 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.02 CAD, the upside of Revive Therapeutics Ltd is -338.90%.
With the market price of 0.02 CAD and our fair value calculation, Revive Therapeutics Ltd (RVV.CN) is not a good investment. Investing in RVV.CN stocks now will result in a potential loss of 338.90%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 5Y Avg | |
| Net income | -5.38 | -20.12 | -17.81 | -6.32 | -5.62 | -11.05 |
| YoY growth | -300.46% | -273.84% | 11.49% | 64.50% | 11.11% | -97.44% |
| Market Cap (mil) | 10.46 |
| P/E | |
| Forward P/E |
| EPS | -0.01 |
| Avg earnings growth rate | -97.44% |
| TTM earnings | -4.00 |